Skip to search formSkip to main contentSkip to account menu

taglutimide

Known as: 2-(2,6-dioxo-3-piperidinyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione, 2-(bicyclo(2.2.1)heptane-2-endo,3-endo-dicarboximido)glutarimide, biglumide 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

AnticonvulsantsHypnotics and SedativesThalidomide

Narrower (1)

K-2004
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1979
1979
Pharmacological properties of taglutimide, a new sedative-hypnotic drug.
2-[Bicyclo(2,2,1)heptane-2-endo-3-endo-dicarboximido]-glutarimide (taglutimide, K-2004) proved to be a new sedative-hypnotic drug… 
1979
1979
Pharmacokinetics and metabolism of taglutimide (K-2004) in the rat.
Absorption, blood level course, renal, fecal, and biliary elimination and the metabolisation of 2-(bicyclo[2,2,1]-heptane-2-endo… 
1978
1978
[Thalidomide analogs. 10. Transplacental distribution kinetics of biglumide in the mouse].
The time course of the distribution of the total radioactivity, the unchanged drug, and the metabolites of biglumide (1) between… 
1977
1977
[Teratologic-neurotoxicologic studies on biglumide (K-2004) and thalidomide].
Comparison of the teratogenic and neurotoxic influence of thalidomide with the new hypnosedative preparation Biglumide (K-2004… 
1977
1977
[Thalidomide analogs 9. Blood level course and organ distribution of biglumide (K-2004) in the mouse].